Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman
04 12월 2024 - 11:00PM
Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”)
(NASDAQ: AIFF), an Artificial Intelligence (“AI”) company
developing innovative solutions that improve brain health outcomes
for patients with neurological and mental disorders, today
announced the appointment of current director of the Board, Greg
Lipschitz, as Executive Chairman, effective as of December 3, 2024.
“I look forward to taking on a more active
leadership role as Executive Chairman,” said Greg Lipschitz, newly
appointed Executive Chairman of Firefly. “I believe that Firefly is
uniquely positioned at the intersection of artificial intelligence
and brain health that I have long been passionate about, and I look
forward to continuing my journey with the Company in this next
chapter.”
Mr. Lipschitz has served as Firefly’s director
since December 2022. Mr. Lipschitz has over 13 years of combined
experience in private equity, merchant banking, capital markets and
finance. From June 2018 to February 2024, Mr. Lipschitz served as
the Vice President of Lazer Capital. He currently serves as the
Managing Director of Old Stone Advisors, a financial advisory firm.
Mr. Lipschitz has advised on over $1 billion of transactions. He is
a Chartered Financial Analyst and received his bachelor’s degree in
business from the Richard Ivey Business School at the University of
Western Ontario.
Firefly’s Board of Directors welcomed Mr.
Lipschitz to the new expanded role and commented, “Greg brings
extensive capital markets knowledge to the Company and has been a
valuable asset in moving the Company agenda forward over the last
three years. At this critical juncture heading into the new year as
we commercialize our technology, the Board has decided that it is
in the best interest of the Company and our shareholders to
transition him to the Executive Chairman role.”
Mr. David Johnson has resigned from the board of
Firefly and stepped down as its Executive Chairman, effective as of
November 30, 2024. This was not the result of any disagreement
between Mr. Johnson and the Company, its management, the Board or
any committee of the Board on any matter relating to the Company’s
operations, policies or practices, or any other matter.
The Firefly board also thanked Mr. Johnson for
his contributions to the Company and wished him well in his future
endeavors.
About Firefly
Firefly (NASDAQ: AIFF) is an Artificial
Intelligence (“AI”) company developing innovative solutions that
improve brain health outcomes for patients with neurological and
mental disorders. Firefly’s FDA-510(k) cleared Brain Network
Analytics (BNA™) technology revolutionizes diagnostic and treatment
monitoring methods for conditions such as depression, dementia,
anxiety disorders, concussions, and ADHD. Over the past 15 years,
Firefly has built a comprehensive database of brain wave tests,
securing patent protection, and achieving FDA clearance. The
Company is now launching BNA™ commercially, targeting
pharmaceutical companies engaged in drug research and clinical
trials, as well as medical practitioners for clinical use.
Brain Network Analytics was developed using
artificial intelligence and machine learning on Firefly’s extensive
proprietary database of standardized, high-definition longitudinal
electroencephalograms (EEGs) of over 17,000 patients representing
twelve disorders, as well as clinically normal patients. BNA™, in
conjunction with an FDA-cleared EEG system, can provide clinicians
with comprehensive insights into brain function. These insights can
enhance a clinician’s ability to accurately diagnose mental and
cognitive disorders and to evaluate what therapy and/or drug is
best suited to optimize a patient’s outcome.
Please
visit https://fireflyneuro.com/ for more information.
Forward-Looking
StatementsCertain statements in this press release may
constitute “forward-looking statements” for purposes of the federal
securities laws concerning Firefly. These forward-looking
statements include express or implied statements relating to
Firefly’s management teams’ expectations, hopes, beliefs,
intentions, or strategies regarding the future. In addition, any
statements that refer to projections, forecasts or other
characterizations of future events or circumstances, including any
underlying assumptions, are forward-looking statements. The words
“anticipate,” “believe,” “contemplate,” “continue,” “could,”
“estimate,” “expect,” “intends,” “may,” “might,” “plan,”
“possible,” “potential,” “predict,” “project,” “should,” “will,”
“would” and similar expressions may identify forward-looking
statements, but the absence of these words does not mean that a
statement is not forward-looking. These forward-looking statements
are based on current expectations and beliefs concerning future
developments and their potential effects. There can be no assurance
that future developments affecting Firefly will be those that have
been anticipated. These forward-looking statements involve a number
of risks, uncertainties (some of which are beyond Firefly’s
control) or other assumptions that may cause actual results or
performance to be materially different from those expressed or
implied by these forward-looking statements. These risks and
uncertainties include, but are not limited to: risks related to
development and commercialization of BNATM technology; risks
related to Firefly’s ability to recognize the anticipated benefits
of the merger (the “Merger”) with WaveDancer, Inc. (“WaveDancer”);
risks related to Firefly’s ability to correctly estimate its
operating expenses and unanticipated spending and costs that could
reduce Firefly’s cash resources; the ability of Firefly to protect
its intellectual property rights; competitive responses to the
Merger; unexpected costs, charges or expenses resulting from the
Merger; potential adverse reactions or changes to business
relationships resulting from the completion of the Merger;
legislative, regulatory, political and economic developments; and
those factors described under the heading “Risk Factors” in the in
the registration statement on Form S-4 filed by WaveDancer with the
Securities and Exchange Commission on January 22, 2024, as amended,
and declared effective on February 6, 2024. Should one or more of
these risks or uncertainties materialize, or should any of
Firefly’s assumptions prove incorrect, actual results may vary in
material respects from those projected in these forward-looking
statements. It is not possible to predict or identify all such
risks. Forward-looking statements included in this press release
only speak as of the date they are made, and Firefly does not
undertake any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as may be required under applicable securities
laws.
Investor ContactKCSA Strategic
CommunicationsValter Pinto or Jack Perkins(212)
896-1254Firefly@KCSA.com
Media ContactKCSA Strategic
CommunicationsRaquel Cona, Vice President(516)
779-2630Rcona@KCSA.com
Firefly Neuroscience (NASDAQ:AIFF)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Firefly Neuroscience (NASDAQ:AIFF)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025